Low-Molecular-Weight Heparin and Early Neurologic Deterioration in Acute Stroke Caused by Large Artery Occlusive Disease

Study Questions:

What are the risks and benefits associated with the use of low molecular weight heparin (LMWH) in early ischemic stroke patients?